维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：期刊名="Pharm Stat"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Missing data - prevention and analysis 显示文摘	Soon G	2009	J Bio- pharm Stat2009，19，：	1
2	Recommendations on the Statistical Analysis of the Comet Assay 显示文摘	Bright J Aylott M Bate S	2011	Pharm Stat2011，10，6：	1
3	Exploratory assess- ment of dose proportionality: review of current approaches and proposal for a practical criterion 显示文摘	Hummel J McKendrick S Brindley C	2009	Pharm Stat2009，8，：	1
4	Sequen- tial design approaches for bioequivalence studies with crossover designs 显示文摘	Potvin D DiLiberti CE Hauck WW	2008	Pharm Stat2008，7，4：	1
5	An Assessment of the Statistical Methods Used to Analyse Toxicology Studies 显示文摘	Jarvis P Saul J Aylott M	2011	Pharm Stat2011，10，6：	1
6	Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies 显示文摘	Austin PC	2011	Pharm Stat2011，10，2：	1
7	Wilcoxon's slgned-rank statistic: what null hypothesis and why it matters显示文摘	Li H Johnson T	2014	Pharm Stat2014，13，5：	1
8	Bonferroni-based correc-tion factor for multiple,correlated endpoints显示文摘	SHI Q PAVEY ES CARTER RE	2012	Pharm Stat2012，，4：	1
9	Mixture and mixture-process variable experiments for pharmaceutical applications显示文摘	ANDERSON-COOK C M GOLDFARD H B BORROR C M	2004	Pharm Stat2004，3，4：	1
10	Establishing consisten- cy across all regions in a multi-regional clinical trial显示文摘	TSOU HH JAMES HH CHEN YM	2012	Pharm Stat2012，11，4：	1
11	Minimal important difference thresholds and the standard error of measurement: Is there a connection显示文摘	Wyrwich K W	2004	J Bio- pharm Stat2004，14，1：	1
12	An inferential procedure for the probability of passing the USP dissolution test显示文摘	CHIANG C CHEN CF HUANG MY	2012	Pharm Stat2012，11，1：	1
13	Exploratory assessment of dose proportionality:review of current approaches and proposal for a practical criterion显示文摘	Hummel J McKendrick S Brindley C	2009	Pharm Stat2009，8，1：	1
14	Sample size con- siderations for Japanese patients in a multi-regional tri- al based on MHLW guidance显示文摘	Quan H Zhao PL Zhang J	2010	Pharm Stat2010，9，2：	1
15	An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials 显示文摘	Huang Y Chang WJ Hsiao CF	2013	Pharm Stat2013，12，2：	1
16	Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models 显示文摘	Ratitch B O'Kelly M Tosiello R	2013	Pharm Stat2013，12，6：	1
17	Estimation of the limit of detection for quantalresponse bioassays显示文摘	van den Heuvel E	2011	Pharm Stat2011，10，3：	1
18	Exploratory assessment of dose proportionality:review of current approaches and proposal for a practical criterion显示文摘	Hummel J McKendrick S Brindley C	2009	Pharm Stat2009，8，：	1
19	Sample size considera-tions for Japanese patients in a multi-reginoal trial based on MHLWguidance显示文摘	QUAN H ZHAO PL ZHANG JT	2010	Pharm Stat2010，9，2：	1
20	Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis 显示文摘	Ploeger BA Holford NH	2009	Pharm Stat2009，8，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示